Safety of BNT162b2 mRNA COVID-19 vaccine in children with chronic kidney disease: a national population study from South Korea.

Young June ChoeYo-Han AhnEunsun GwakEunseo JoJinseob KimSeung-Ah Choe

Published in: Pediatric nephrology (Berlin, Germany) (2023)

In this national cohort study of adolescents with CKD in South Korea, we observed no evidence of increased risk of adverse events following BNT162b2 vaccination. Our finding offers insights into the safety of COVID-19 vaccines, empowering adolescent patients with CKD and their caregivers to make informed decisions.

Keyphrases

chronic kidney disease
young adults
coronavirus disease
end stage renal disease
sars cov
quality improvement
palliative care
physical activity
mental health
peritoneal dialysis